Skip to content

Effect of hair product on hair growth, dandruff and hair fall

To evaluate the in-vivo safety and efficacy of hair care formulation in terms of reduction in hairfall, reduction in dandruff and improvement in hair growth on healthy human subjects - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/071942
Enrollment
36
Registered
2024-08-06
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hair serum: Product is applied on whole head including scalp and shafts thrice a week for the period of 28days. Control Intervention1: Nil: NA

Sponsors

Emami Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian / Asian male & female subjects. 2)Healthy subjects 3)Having mild to moderate hair fall. 4)Having mild to moderate dandruff.

Exclusion criteria

Exclusion criteria: 1)Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give her assent by not signing the consent form. 3)Taking part in another study liable to interfere with this study. 4)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area. 5)Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months) 6)Having a progressive asthma (either under treatment or last fit in the last 2 years) 7)Being epileptic 8)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 9)Having cutaneous hypersensitivity 10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products 11)Following a chronic or intermittent medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, anti-coagulants, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 12)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months

Design outcomes

Primary

MeasureTime frame
Reduction in hairfall, reduction in dandruff and improvement in hair growthTimepoint: Baseline, 14 days, 28 days

Secondary

MeasureTime frame
NilTimepoint: NA

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026